Biogen signs lease for Kendall Common as part of multi-year real estate optimization plan to modernize its facilities and consolidate its ...
In the first major deal at MIT’s ambitious overhaul of the old Volpe Center in Kendall Square, Cambridge drugmaker Biogen ...
Biogen Inc. plans to move its headquarters into a 16-story Kendall Square tower to be developed by MIT and BioMed Realty ...
There’s been no shortage of either in recent weeks. Plunging valuations across the biotech sector were thrust into the ...
Shares of Biogen Inc. BIIB shed 1.16% to $141.43 Wednesday, on what proved to be an all-around great trading session for the ...
Barchart on MSN5d
How Is Biogen's Stock Performance Compared to Other Biotech Stocks?With a market cap of $21 billion, Cambridge, Massachusetts-based Biogen Inc. (BIIB) discovers, develops, manufactures, and ...
Last year, the first phase 3 trial of Sage Therapeutics and Biogen's antidepressant hopeful zuranolone hit its efficacy targets, but raised doubts about the durability of the response. Now ...
Biogen has revealed encouraging phase 2 results with its anti-CD38 antibody felzartamab in rare kidney disease IgA nephropathy (IgAN), which it hopes could join a series of first-in-class ...
After hours: March 21 at 7:27:47 PM EDT Loading Chart for BIIB ...
As of 3:25:19 PM EDT. Market Open.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback